Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Quantexa Secures Top Ten Spot in Chartis’ 2025 Financial Crime and Compliance 50 Rankings
-
Stefanini Positioned as a Niche Player in Service Integration and Management (SIAM)
-
MEXC Dominates Token Listings with Highest Success Rate and Speed – TokenInsight Report
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
JuicyChat.AI Unveils NSFW AI Girlfriend Chatbot in 2025, Redefining Virtual Companionship
-
Equinor presents 2024 Annual report
-
PRE ANNOUNCEMENT OF CERTIFICATE AUCTION TENDER
-
DallBogg announces collaboration with OCTO Telematics
-
Form 8.3 - Equals Group Plc
-
Nokia launches FastMile Gateway 4, enhancing its Wi-Fi 7 enabled FWA portfolio
-
Pacific Green Completes Sale of 250MW / 500 MWh Limestone Coast North Battery Energy Park Development
-
NTG Nordic Transport Group acquires DTK
-
Borregaard ASA: Notice of Borregaard’s Annual General Meeting 2025
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Form 8.5 (EPT/RI)-Thruvision Group plc
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Northern Karelia Cooperative Society (PKO) has chosen Aino’s SaaS platform
-
FORVIA PRICES €750 MILLION OF 5-YEAR SENIOR NOTES TO FULLY REFINANCE ITS 3.125% NOTES DUE 2026
-
Borregaard ASA: Annual Report 2024
-
Form 8.5 (EPT/RI)-De La Rue plc
-
Notice convening the Annual General Meeting in BioPorto A/S
-
ageas SA/NV organises Extraordinary General Meeting of Shareholders
-
Pharma Equity Group A/S - Annual Report 2024
-
BioPorto announces the Annual Report for 2024
-
Diversified Energy Announces Details of Share Buyback Program
-
Director Shareholdings
-
New Zscaler AI Security Report Reveals an Over 3,000% Surge in Enterprise Use of AI/ML Tools
-
PDMR Shareholdings
-
IPOPEMA Initiates Coverage of Šiaulių Bankas with a Buy Rating and a Target Price of EUR 1.20
-
Calling All Smart Cities & IoT Innovators: 2025 Future Digital Awards Now Open
-
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
-
Announcement of Fixed Income Investor Meetings
-
Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
-
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
-
Intermediate Capital Group plc: Notification of Major Holdings
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Calling All Smart Cities & IoT Innovators: 2025 Future Digital Awards Now Open
-
Norsk Hydro: Resignation of board member of Norsk Hydro ASA
-
AI-Powered Quality Inspection in Manufacturing with Lenovo & Trifork
-
EXOSENS JOINS THE SBF 120 INDEX
-
Transaction in Own Shares
-
VEON to Proceed with USD 35 Million Share Buyback
-
VEON FY24 and 4Q24 Trading Update: Strong Delivery in 2024, Digital Services Driving Growth
-
Valneva Reports Full Year 2024 Results and Provides Business Updates and Outlook
-
Start of Day Message
-
Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline
-
Sodexo First half Fiscal 2025 estimates and full year guidance update
-
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market
-
IBA reports solid Full Year 2024 results
-
Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation
